On the other hand, administration of saroglitazar and curcumin significantly reduced the level of pro-inflammatory cytokines (IL-1, IL-6, TNF-α, TGF- β1, COX-2, and MCP-1) that were enhanced abnormally in the liver tissues of NAFLD. The gene discussed is CCL2; the disease is metabolic dysfunction-associated steatotic liver disease.